An 8-2 panel vote finds that benefits of using Dexcom’s G5 CGM for dosing insulin outweigh the risks; patient advocates provide compelling testimonies
Type 1 Diabetes News
Type 1 Diabetes is a chronic condition in which your body loses the ability to produce insulin, which is necessary for most cells to convert food into energy and regulate blood sugar levels.
48 readers recommended
Brings real-time insulin tracking, history, and a bolus calculator to injectors; launch in 2017
41 readers recommended
JDRF and Helmsley Charitable Trust workshop highlights future goals and expectations for glucose-responsive insulin.
51 readers recommended
Approaching the conversation, words and phrases to use, and more!
41 readers recommended
Renowned pediatric endocrinologist offers a lens into what it means to be a caregiver.
34 readers recommended
Strong results from the IMPACT study in low-A1c users.
133 readers recommended
Six systems expected by 2019, plus an FAQ! Which system is right for me?
62 readers recommended
How sports can be a platform to tackle diabetes awareness and stigma.
37 readers recommended
College Diabetes Network’s free “Off to College” booklets on overcoming diabetes challenges during the college transition
31 readers recommended
Portion control, increasing the nutritional content of meals, and more
31 readers recommended
Why the FDA may change its definition of healthy, and how it could impact people with diabetes. Plus, what's coming to nutrition labels?
58 readers recommended
80 days, 5 lbs of weight loss, and my strongest blood glucose numbers ever?
55 readers recommended
MannKind has re-launched the inhaled mealtime insulin, Afrezza, alongside new initiatives to promote the product
32 readers recommended
The diaTribe Foundation and TCOYD host discussion at ADA focusing on access, outcomes beyond A1c, and future expectations
52 readers recommended
Faster version of Novo Nordisk’s NovoLog approved in the US for type 1 and type 2 diabetes, launch expected as early as end of 2017
45 readers recommended
People with type 1 or type 2 diabetes on intensive insulin therapy can qualify. A major win for the diabetes community following years of patient advocacy!
36 readers recommended
The 2017 Patient Voices Contest is currently open; winners will receive a full scholarship to attend the 2017 DiabetesMine Innovation Summit in Palo Alto
53 readers recommended
A six-week study of Tandem’s first automated insulin delivery device with Dexcom’s G5 CGM
53 readers recommended
Cash-pay strips with good accuracy and co-pay programs to save money
46 readers recommended
New apps and software updates from mySugr, Insulia, One Drop, as well as food and weight loss apps